Diabetes & Endocrinology News

• NKF 2025 Chlorthalidone Increases Kidney Stone Recurrence A secondary analysis of the DCP shows that, compared with hydrochlorothiazide, chlorthalidone significantly increases the risk of kidney stones — but only among those with prior stones.
  Medscape Medical News, April 11, 2025
• Malnutrition-Related Diabetes Officially Named ‘Type 5’ The new name and endorsement at the World Diabetes Congress are seen as long overdue recognition that will spur more research.
  Medscape Medical News, April 11, 2025
• ATTD 2025 GLP-1s Eyed as Key to Managing T1D With Obesity As obesity rates rise among individuals with T1D, GLP-1 agonist medications, indicated for T2D and weight loss, are increasingly viewed as adjuncts to insulin.
  Medscape Medical News, April 11, 2025
• Weight-Loss Surgery Instead of GLP-1s? In the long term, bariatric surgery is more cost-effective than new anti-obesity medications, research finds, triggering a call to suggest patients consider surgery — or both.
  Medscape Medical News, April 11, 2025
• Online Program Helps Women Improve Sexual Dysfunction Both mindfulness-based therapy and cognitive-behavioral therapy appear to be effective, allowing users to decide which approach may work better for them.
  Medscape Medical News, April 11, 2025
• Popular Joint Supplement Cuts Nephropathy Risk in T2D People with type 2 diabetes who regularly use the supplement glucosamine have a lower risk for microvascular complications and diabetic nephropathy, a prospective observational study finds.
  Medscape Medical News, April 11, 2025
• Alert FDA Clears Dexcom G7 CGM for 15-Day Wear The US Food and Drug Administration has cleared the latest version to last 5 days longer than previously for adult users.
  Medscape Medical News, April 10, 2025
• Sucralose Affects Brain Mechanisms That Regulate Appetite The noncaloric sweetener sucralose appears to influence how the hypothalamus interprets sweet taste and metabolic signals, potentially influencing appetite regulation over time.
  Medscape Medical News, April 10, 2025
• Inflammatory Marker Predicts Liver Cancer Risk in T2D An inflammatory biomarker, YKL-40, serves as a reliable prognostic marker for liver and bladder cancers in patients with newly diagnosed T2D, outperforming CRP for these cancers.
  Medscape News UK, April 10, 2025
• Mediterranean Diet and Exercise Boost Bone Health in Seniors An energy-restricted Mediterranean diet plus physical activity can mitigate weight loss and age-related decline in bone mineral density in older women with metabolic syndrome and overweight or obesity.
  Medscape Medical News, April 10, 2025
• AAN 2025 AI-Powered Wearable Calms Essential Tremor The Felix NeuroAI wristband delivers tailored and dynamic electrical stimulation to the ulnar, median, and radial nerves throughout the day to relieve essential tremor.
  Medscape Medical News, April 10, 2025
• The Era of Compounded GLP-1 Drugs Is Over. What Now? Physicians are turning to other options, including older, cheaper medications, as compounding GLP-1s comes to an end.
  Medscape Medical News, April 10, 2025
• Cancer Deaths Fall in Europe, but Not Across All Types A new study has revealed significant reductions in cancer deaths across Europe, yet critical challenges persist for specific tumour types.
  Medscape News UK, April 10, 2025
• Knee OA Pain? Yoga, Strengthening Exercises May Help Equally Over a 12-week period, yoga proves noninferior to strengthening exercises in significantly reducing knee pain.
  Medscape Medical News, April 10, 2025
• ACC 2025 Rivaroxaban Comparable to Warfarin for LV Thrombus Post-MI The direct oral anticoagulant is an effective alternative to warfarin that offers predictable dosing without the need for routine monitoring in patients with STEMI, the RIVAWAR trial shows.
  Medscape Medical News, April 10, 2025
• Experts Push Back on RFK Jr’s Infection Comments The new Secretary of Health and Human Services has made claims about measles and other communicable diseases that could lead to sickness, and even death, his critics claim.
  Medscape Medical News, April 09, 2025
• Surgery Tops Lifestyle Changes in Patients With Cirrhosis The cost-effectiveness of the surgery, particularly for those with cirrhosis, is significant compared with those only receiving a lifestyle modification program.
  Medscape Medical News, April 09, 2025
• ATTD 2025 Continuous Ketone Monitoring: Essential or Optional? Two endocrinologists who live with type 1 diabetes debate this issue at the Advanced Technologies & Treatments for Diabetes (ATTD) 2025 meeting.
  Medscape Medical News, April 09, 2025
• ACC 2025 Novel Drug Moving Forward for Lp(a) A single dose of an siRNA molecule reduces elevated lipoprotein(a) — a major, but to date, largely untreatable risk factor for cardiovascular disease — a phase 2 trial shows.
  Medscape Medical News, April 08, 2025
• More Evidence Ties Diabetes Meds to Lower Dementia Risk GLP-1 receptor agonists and SGLT2 inhibitors are associated with a lower risk of dementia, suggesting these drugs may have a neuroprotective effect.
  Medscape Medical News, April 08, 2025